INmune Bio, Inc. Announces Pricing of Initial Public Offering
15 janv. 2019 15h00 HE
|
INmune Bio, Inc.
LA JOLLA, CA, Jan. 15, 2019 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (“INmune” or the “Company”), an immunotherapy company focused on developing therapies that harness the patient’s innate immune...